Financial statements Symbio-Lab
Balance sheet of Symbio-Lab
Company age:
Age:
14 y. 21 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SYMBIO-LAB
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 377 025,72 | 521 659,64 |
| A. Fixed assets | 47 506,18 | 27 988,79 |
| B. Current assets | 329 519,54 | 493 670,85 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 377 025,72 | 521 659,64 |
| A. Equity | -74 787,89 | 67 566,42 |
| B. Liabilities and provisions for liabilities | 451 813,61 | 454 093,22 |
| I. Long-term liabilities | 13 328,00 | 0,00 |
| II. Short-term liabilities | 438 485,61 | 454 093,22 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.